作者:
Giovanni,Corso [1]
;
Carmen,Criscitiello [2]
;
Luca,Nicosia [3]
;
Filippo,Pesapane [2]
;
Elisa,Vicini [4]
;
Francesca,Magnoni [5]
;
Andrea,Sibilio [5]
;
Cristina,Zanzottera [1]
;
Alessandra Margherita,De Scalzi [1]
;
Sara,Mannucci [6]
;
Monica,Marabelli [7]
;
Mariarosaria,Calvello [1]
;
Irene,Feroce [7]
;
Paola,Zagami [7]
;
Francesca Maria,Porta [7]
;
Antonio,Toesca [8]
;
Paolo,Tarantino [7]
;
Eleonora,Nicolò [4]
;
Giovanni,Mazzarol [9]
;
Carlo,La Vecchia [9]
;
Bernardo,Bonanni [10]
;
Maria Cristina,Leonardi [4]
;
Paolo,Veronesi [11]
;
Nicola,Fusco [12]
作者单位:
Division of Breast Surgery, European Institute of Oncology (IEO), IRCCS.
[1]
Department of Oncology and Hemato-Oncology, University of Milan.
[2]
European Cancer Prevention Organization (ECP).
[3]
Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology (IEO), IRCCS.
[4]
Breast Imaging Division, Radiology Department, European Institute of Oncology (IEO), IRCCS, Milan.
[5]
Division of Breast Surgery Forlì (Ravenna), AUSL Romagna, Ravenna.
[6]
Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO), IRCCS, Milan.
[7]
Division of Hematology, Clinica Moncucco, Lugano, Switzerland.
[8]
Department of Biomedical, Surgical and Dental Sciences.
[9]
Candiolo Cancer Institute, FPO - IRCCS, Candiolo (TO), Italy.
[10]
Division of Breast Oncology, Dana-Farber Cancer Institute, MA, USA.
[11]
Harvard Medical School, Boston, MA, USA.
[12]
Division of Pathology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
[13]
Department of Clinical Sciences and Community Health, University of Milan, Milan, and.
[14]
Division of Radiotherapy, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
[15]
DOI
10.1097/CEJ.0000000000000794
PMID
37021548
发布时间
2023-12-06